---
title: "Dongcheng Biochem: Plans to acquire minority shareholder equity in its controlling subsidiary Lanacheng for 36 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238071227.md"
description: "Dongcheng Biochem announced that the company intends to acquire 1.65% of the shares held by Shenzhen Jinglin Jingying Equity Investment Fund Partnership, a minority shareholder of its controlling subsidiary Yantai Lannacheng Biotechnology Co., Ltd., for approximately RMB 36 million"
datetime: "2025-04-29T13:17:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238071227.md)
  - [en](https://longbridge.com/en/news/238071227.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238071227.md)
generator: "portal-rs"
---

# Dongcheng Biochem: Plans to acquire minority shareholder equity in its controlling subsidiary Lanacheng for 36 million yuan

Dongcheng Biochem announced that the company plans to acquire 1.65% of the shares held by Shenzhen Jinglin Jingying Equity Investment Fund Partnership, a minority shareholder of its controlling subsidiary Yantai Lanna Biotechnology Co., Ltd., for approximately RMB 36 million

### Related Stocks

- [002675.CN](https://longbridge.com/en/quote/002675.CN.md)

## Related News & Research

- [Retirement portfolios are getting eaten up by inflation. Here are some assets to consider](https://longbridge.com/en/news/297272260.md)
- [Quinto Resources Provides Corporate Updates and Announces Reinstatement of Trading and AGM](https://longbridge.com/en/news/297236929.md)
- [Vienna Insurance Group (WBAG:VIG) Gains On H1 Results As Fair Value Questions Linger](https://longbridge.com/en/news/297147465.md)
- [AXIATA: Earnings and dividends surged, driven by merger synergies, 5G investments, and portfolio growth](https://longbridge.com/en/news/297337287.md)
- [08:39 ETPredoc Launches Curated Data Layer to Make Fragmented Medical Records Usable](https://longbridge.com/en/news/297187951.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**